This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow AAP Parent Pages
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Committee on Quality Improvement
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Committee on Quality Improvement,
Related Collections
Right arrow Neurology & Psychiatry
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 108 No. 4 October 2001, pp. 1033-1044

AMERICAN ACADEMY OF PEDIATRICS:
Clinical Practice Guideline: Treatment of the School-Aged Child With Attention-Deficit/Hyperactivity Disorder

Subcommittee on Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvement

This clinical practice guideline provides evidence-based recommendations for the treatment of children diagnosed with attention-deficit/hyperactivity disorder (ADHD). This guideline, the second in a set of policies on this condition, is intended for use by clinicians working in primary care settings. The initiation of treatment requires the accurate establishment of a diagnosis of ADHD; the American Academy of Pediatrics (AAP) clinical practice guideline on diagnosis of children with ADHD1 provides direction in appropriately diagnosing this disorder.

The AAP Committee on Quality Improvement selected a subcommittee composed of primary care and developmental-behavioral pediatricians and other experts in the fields of neurology, psychology, child psychiatry, education, family practice, and epidemiology. The subcommittee partnered with the Agency for Healthcare Research and Quality and the Evidence-based Practice Center at McMaster University, Ontario, Canada, to develop the evidence base of literature on this topic.2 The resulting systematic review, along with other major studies in this area, was used to formulate recommendations for treatment of children with ADHD. The subcommittee also reviewed the multimodal treatment study of children with ADHD3 and the Canadian Coordinating Office for Health Technology Assessment report (CCOHTA).4 Subcommittee decisions were made by consensus where definitive evidence was not available. The subcommittee report underwent extensive review by sections and committees of the AAP as well as by numerous external organizations before approval from the AAP Board of Directors.

The guideline contains the following recommendations for the treatment of a child diagnosed with ADHD:

  • Primary care clinicians should establish a treatment program that recognizes ADHD as a chronic condition.
  • The treating clinician, parents, and child, in collaboration with school personnel, should specify appropriate target outcomes to guide management.
  • The clinician should recommend stimulant medication and/or behavior therapy as appropriate to improve target outcomes in children with ADHD.
  • When the selected management for a child with ADHD has not met target outcomes, clinicians should evaluate the original diagnosis, use of all appropriate treatments, adherence to the treatment plan, and presence of coexisting conditions.
  • The clinician should periodically provide a systematic follow-up for the child with ADHD. Monitoring should be directed to target outcomes and adverse effects, with information gathered from parents, teachers, and the child.

.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Am J Health Syst PharmHome page
B. Popovic, P. Bhattacharya, and L. Sivaswamy
Lisdexamfetamine: A prodrug for the treatment of attention-deficit/hyperactivity disorder
Am. J. Health Syst. Pharm., November 15, 2009; 66(22): 2005 - 2012.
[Abstract] [Full Text] [PDF]

Home page
 cfpHome page
M. McLeod, T. Laubscher, L. Regier, and B. Jensen
Taking the stress out of individualizing ADHD drug therapy
Can Fam Physician, September 1, 2009; 55(9): 895 - 898.
[Full Text] [PDF]

Home page
 Psychiatr. Serv.Home page
B. D. Fulton, R. M. Scheffler, S. P. Hinshaw, P. Levine, S. Stone, T. T. Brown, and S. Modrek
National Variation of ADHD Diagnostic Prevalence and Medication Use: Health Care Providers and Education Policies
Psychiatr Serv, August 1, 2009; 60(8): 1075 - 1083.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
W. B. Brinkman, S. N. Sherman, A. R. Zmitrovich, M. O. Visscher, L. E. Crosby, K. J. Phelan, and E. F. Donovan
Parental Angst Making and Revisiting Decisions About Treatment of Attention-Deficit/Hyperactivity Disorder
Pediatrics, August 1, 2009; 124(2): 580 - 589.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
Committee on Psychosocial Aspects of Child and Fam
The Future of Pediatrics: Mental Health Competencies for Pediatric Primary Care
Pediatrics, July 1, 2009; 124(1): 410 - 421.
[Abstract] [Full Text] [PDF]

Home page
 REVIEW OF EDUCATIONAL RESEARCHHome page
J. Harrison, B. Thompson, and K. J. Vannest
Interpreting the Evidence for Effective Interventions to Increase the Academic Performance of Students With ADHD: Relevance of the Statistical Significance Controversy
Review of Educational Research, June 1, 2009; 79(2): 740 - 775.
[Abstract] [Full Text] [PDF]

Home page
 J PsychopharmacolHome page
D. Jasinski and S Krishnan
Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers
J Psychopharmacol, June 1, 2009; 23(4): 410 - 418.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
I. Berger and N. Felsenthal-Berger
Attention-Deficit Hyperactivity Disorder (ADHD) and Birth Order
J Child Neurol, June 1, 2009; 24(6): 692 - 696.
[Abstract] [PDF]

Home page
 J PsychopharmacolHome page
D. Jasinski and S Krishnan
Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse
J Psychopharmacol, June 1, 2009; 23(4): 419 - 427.
[Abstract] [PDF]

Home page
 The Annals of PharmacotherapyHome page
B. Chavez, M. A Sopko Jr., M. J Ehret, R. E Paulino, K. R Goldberg, K. Angstadt, and G. T Bogart
An Update on Central Nervous System Stimulant Formulations in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
Ann. Pharmacother., June 1, 2009; 43(6): 1084 - 1095.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. E.K. Stein, S. M. Horwitz, A. Storfer-Isser, A. M. Heneghan, K. E. Hoagwood, K. J. Kelleher, K. G. O'Connor, and L. Olson
Attention-Deficit/Hyperactivity Disorder: How Much Responsibility Are Pediatricians Taking?
Pediatrics, January 1, 2009; 123(1): 248 - 255.
[Abstract] [Full Text] [PDF]

Home page
 Circ Cardiovasc Qual OutcomesHome page
L. K. Leslie, M. E. Alexander, T. A. Trikalinos, J. T. Cohen, S. K. Parsons, and J. W. Newburger
Reexamining the Emperor's New Clothes: Ambiguities in Current Cardiac Screening Recommendations for Youth With Attention Deficit Hyperactivity Disorder
Circ Cardiovasc Qual Outcomes, November 1, 2008; 1(2): 134 - 137.
[Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
T. E. Wilens, J. Adamson, M. C. Monuteaux, S. V. Faraone, M. Schillinger, D. Westerberg, and J. Biederman
Effect of Prior Stimulant Treatment for Attention-Deficit/Hyperactivity Disorder on Subsequent Risk for Cigarette Smoking and Alcohol and Drug Use Disorders in Adolescents
Arch Pediatr Adolesc Med, October 1, 2008; 162(10): 916 - 921.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. Conway, K. K. Wong, C. O'Connell, and A. E. Warren
Cardiovascular Risk Screening Before Starting Stimulant Medications and Prescribing Practices of Canadian Physicians: Impact of the Health Canada Advisory
Pediatrics, October 1, 2008; 122(4): e828 - e834.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Emotional and Behavioral DisordersHome page
L. K. Leslie, K. M. Lambros, G. A. Aarons, R. A. Haine, and R. L. Hough
School-Based Service Use by Youth With ADHD in Public-Sector Settings
Journal of Emotional and Behavioral Disorders, September 1, 2008; 16(3): 163 - 177.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
I. Berger, T. Dor, Y. Nevo, and G. Goldzweig
Attitudes Toward Attention-Deficit Hyperactivity Disorder (ADHD) Treatment: Parents' and Children's Perspectives
J Child Neurol, September 1, 2008; 23(9): 1036 - 1042.
[Abstract] [PDF]

Home page
 PediatricsHome page
S. L. Toomey, J. Finkelstein, and K. Kuhlthau
Does Connection to Primary Care Matter for Children With Attention-Deficit/Hyperactivity Disorder?
Pediatrics, August 1, 2008; 122(2): 368 - 374.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. M. Perrin, R. A. Friedman, T. K. Knilans, the Black Box Working Group, and the Section on Cardiology and Cardiac Surgery
Cardiovascular Monitoring and Stimulant Drugs for Attention-Deficit/Hyperactivity Disorder
Pediatrics, August 1, 2008; 122(2): 451 - 453.
[Full Text] [PDF]

Home page
 FocusHome page
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
Focus, July 1, 2008; 6(3): 401 - 426.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. N. Epstein, J. M. Langberg, P. K. Lichtenstein, B. A. Mainwaring, C. P. Luzader, and L. J. Stark
Community-wide Intervention to Improve the Attention-Deficit/Hyperactivity Disorder Assessment and Treatment Practices of Community Physicians
Pediatrics, July 1, 2008; 122(1): 19 - 27.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
J. H. Newcorn, C. J. Kratochvil, A. J. Allen, C. D. Casat, D. D. Ruff, R. J. Moore, D. Michelson, and Atomoxetine/Methylphenidate Comparative Study Grou
Atomoxetine and Osmotically Released Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder: Acute Comparison and Differential Response
Am J Psychiatry, June 1, 2008; 165(6): 721 - 730.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
V. L. Vetter, J. Elia, C. Erickson, S. Berger, N. Blum, K. Uzark, and C. L. Webb
Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Medications for Attention Deficit/Hyperactivity Disorder: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing
Circulation, May 6, 2008; 117(18): 2407 - 2423.
[Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
S. Mannuzza, R. G. Klein, N. L. Truong, J. L. Moulton III, E. R. Roizen, K. H. Howell, and F. X. Castellanos
Age of Methylphenidate Treatment Initiation in Children With ADHD and Later Substance Abuse: Prospective Follow-Up Into Adulthood
Am J Psychiatry, May 1, 2008; 165(5): 604 - 609.
[Abstract] [Full Text] [PDF]

Home page
 J Atten DisordHome page
M. A. Davidson
Literature Review: ADHD in Adults: A Review of the Literature
J Atten Disord, May 1, 2008; 11(6): 628 - 641.
[Abstract] [PDF]

Home page
 CLIN PEDIATRHome page
A. Heneghan, A. S. Garner, A. Storfer-Isser, K. Kortepeter, R. E. K. Stein, and S. McCue Horwitz
Use of Selective Serotonin Reuptake Inhibitors by Pediatricians: Comparing Attitudes of Primary Care Pediatricians and Child and Adolescent Psychiatrists
Clinical Pediatrics, March 1, 2008; 47(2): 148 - 154.
[Abstract] [PDF]

Home page
 J Atten DisordHome page
A. R. Perwien, C. J. Kratochvil, D. Faries, B. Vaughan, J. Busner, K. E. Saylor, C. M. Buermeyer, S. Kaplan, and R. Swindle
Emotional Expression in Children Treated With ADHD Medication: Development of a New Measure
J Atten Disord, March 1, 2008; 11(5): 568 - 579.
[Abstract] [PDF]

Home page
 PediatricsHome page
T. J. Power, J. A. Mautone, P. H. Manz, L. Frye, and N. J. Blum
Managing Attention-Deficit/Hyperactivity Disorder in Primary Care: A Systematic Analysis of Roles and Challenges
Pediatrics, January 1, 2008; 121(1): e65 - e72.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
L. E. Arnold, R. L. Lindsay, F. A. Lopez, S. E. Jacob, J. Biederman, R. L. Findling, and Y. Ramadan
Treating Attention-Deficit/Hyperactivity Disorder With a Stimulant Transdermal Patch: The Clinical Art
Pediatrics, November 1, 2007; 120(5): 1100 - 1106.
[Abstract] [Full Text] [PDF]

Home page
 J Atten DisordHome page
M. T. Lien, J. S. Carlson, S. Hunter-Oehmke, and K. A. Knapp
A Pilot Investigation of Teachers' Perceptions of Psychotropic Drug Use in Schools
J Atten Disord, September 1, 2007; 11(2): 172 - 177.
[Abstract] [PDF]

Home page
 J Atten DisordHome page
S. V. Faraone, J. Biederman, and B. Zimmerman
An Analysis of Patient Adherence to Treatment During a 1-Year, Open-label Study of OROS(R) Methylphenidate in Children With ADHD
J Atten Disord, September 1, 2007; 11(2): 157 - 166.
[Abstract] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
J. N. Epstein, D. Rabiner, D. E. Johnson, D. P. FitzGerald, A. Chrisman, A. Erkanli, K. K. Sullivan, J. S. March, P. Margolis, E. C. Norton, et al.
Improving Attention-Deficit/Hyperactivity Disorder Treatment Outcomes Through Use of a Collaborative Consultation Treatment Service by Community-Based Pediatricians: A Cluster Randomized Trial
Arch Pediatr Adolesc Med, September 1, 2007; 161(9): 835 - 840.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
T. E. Froehlich, B. P. Lanphear, J. N. Epstein, W. J. Barbaresi, S. K. Katusic, and R. S. Kahn
Prevalence, Recognition, and Treatment of Attention-Deficit/Hyperactivity Disorder in a National Sample of US Children
Arch Pediatr Adolesc Med, September 1, 2007; 161(9): 857 - 864.
[Abstract] [Full Text] [PDF]

Home page
 J Pediatr PsycholHome page
R. T. Brown and J. M. Perrin
Measuring Outcomes in Attention-Deficit/Hyperactivity Disorder
J. Pediatr. Psychol., July 1, 2007; 32(6): 627 - 630.
[Full Text] [PDF]

Home page
 J Pediatr PsycholHome page
W. E. Pelham, E. M. Foster, and J. A. Robb
The Economic Impact of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
J. Pediatr. Psychol., July 1, 2007; 32(6): 711 - 727.
[Abstract] [Full Text] [PDF]

Home page
 J Pediatr PsycholHome page
L. K. Leslie and M. L. Wolraich
ADHD Service Use Patterns in Youth
J. Pediatr. Psychol., July 1, 2007; 32(6): 695 - 710.
[Abstract] [Full Text] [PDF]

Home page
 J Atten DisordHome page
L. Castle, R. E. Aubert, R. R. Verbrugge, M. Khalid, and R. S. Epstein
Trends in Medication Treatment for ADHD
J Atten Disord, May 1, 2007; 10(4): 335 - 342.
[Abstract] [PDF]

Home page
 J Atten DisordHome page
J. Biederman, S. W. Ball, E. Mick, M. C. Monuteaux, R. Kaiser, E. Bristol, and S. V. Faraone
Informativeness of Maternal Reports on the Diagnosis of ADHD: An Analysis of Mother and Youth Reports
J Atten Disord, May 1, 2007; 10(4): 410 - 417.
[Abstract] [PDF]

Home page
 Evid. Based Ment. HealthHome page
M. L Wolraich
Methylphenidate may improve symptoms but does not increase response compared with placebo in preschool children with ADHD
Evid. Based Ment. Health, May 1, 2007; 10(2): 60 - 60.
[Full Text] [PDF]

Home page
 J Child NeurolHome page
Y. Leitner, G. M. Doniger, R. Barak, E. S. Simon, and J. M. Hausdorff
A Novel Multidomain Computerized Cognitive Assessment for Attention-Deficit Hyperactivity Disorder: Evidence for Widespread and Circumscribed Cognitive Deficits
J Child Neurol, March 1, 2007; 22(3): 264 - 276.
[Abstract] [PDF]

Home page
 AAP NewsHome page
S. Cash
ADHD's toll: Research papers at AAP conference paint a picture of the disorder's debilitating social, educational and financial challenges
AAP News, March 1, 2007; 28(3): 20 - 21.
[Full Text] [PDF]

Home page
 Health Aff (Millwood)Home page
R. M. Scheffler, S. P. Hinshaw, S. Modrek, and P. Levine
The Global Market For ADHD Medications
Health Aff., March 1, 2007; 26(2): 450 - 457.
[Abstract] [Full Text] [PDF]

Home page
 The Journal of School NursingHome page
M. T. Dang, D. Warrington, T. Tung, D. Baker, and R. J. Pan
A School-Based Approach to Early Identification and Management of Students with ADHD
The Journal of School Nursing, February 1, 2007; 23(1): 2 - 12.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
S. N. Visser, C. A. Lesesne, and R. Perou
National Estimates and Factors Associated With Medication Treatment for Childhood Attention-Deficit/Hyperactivity Disorder
Pediatrics, February 1, 2007; 119(Supplement_1): S99 - S106.
[Abstract] [Full Text] [PDF]

Home page
 The Family JournalHome page
C. E. Murray and T. L. Murray Jr.
The Family Pharm: An Ethical Consideration of Psychopharmacology in Couple and Family Counseling
The Family Journal, January 1, 2007; 15(1): 65 - 71.
[Abstract] [PDF]

Home page
 PediatricsHome page
M. Knight
Stimulant-Drug Therapy for Attention-Deficit Disorder (With or Without Hyperactivity) and Sudden Cardiac Death
Pediatrics, January 1, 2007; 119(1): 154 - 155.
[Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
R. T. Brown, A. Perwien, D. E. Faries, C. J. Kratochvil, and B. S. Vaughan
Atomoxetine in the Management of Children with ADHD: Effects on Quality of Life and School Functioning
Clinical Pediatrics, November 1, 2006; 45(9): 819 - 827.
[Abstract] [PDF]

Home page
 Psychiatr. Bull.Home page
D. M. Foreman, A. Beedie, and R. Kapuge
Clinic assessment for methylphenidate maintenance therapy in secondary care: are parental questionnaires useful?
Psychiatr. Bull., November 1, 2006; 30(11): 406 - 409.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
D. N Mendhekar and H. S Duggal
Methylphenidate-Induced Rabbit Syndrome
Ann. Pharmacother., November 1, 2006; 40(11): 2076 - 2076.
[Full Text] [PDF]

Home page
 PediatricsHome page
T. E. Wilens, J. B. Prince, T. J. Spencer, and J. Biederman
Stimulants and Sudden Death: What Is a Physician to Do?
Pediatrics, September 1, 2006; 118(3): 1215 - 1219.
[Abstract] [Full Text] [PDF]

Home page
 J Atten DisordHome page
B. Pierrehumbert, M. Bader, S. Thevoz, A. Kinal, and O. Halfon
Hyperactivity and Attention Problems in a Swiss Sample of School-Aged Children: Effects of School Achievement, Child Gender, and Informants.
J Atten Disord, August 1, 2006; 10(1): 65 - 76.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
D. Gilbert
Treatment of Children and Adolescents With Tics and Tourette Syndrome
J Child Neurol, August 1, 2006; 21(8): 690 - 700.
[Abstract] [PDF]

Home page
 BrainHome page
D. L. Gilbert, Z. Wang, F. R. Sallee, K. R. Ridel, S. Merhar, J. Zhang, T. D. Lipps, C. White, N. Badreldin, and E. M. Wassermann
Dopamine transporter genotype influences the physiological response to medication in ADHD
Brain, August 1, 2006; 129(8): 2038 - 2046.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
H.-J. Zhu, J.-S. Wang, C. L. DeVane, R. L. Williard, J. L. Donovan, L. D. Middaugh, B. B. Gibson, K. S. Patrick, and J. S. Markowitz
THE ROLE OF THE POLYMORPHIC EFFLUX TRANSPORTER P-GLYCOPROTEIN ON THE BRAIN ACCUMULATION OF d-METHYLPHENIDATE AND d-AMPHETAMINE
Drug Metab. Dispos., July 1, 2006; 34(7): 1116 - 1121.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
D. F. Connor, T. J. McLaughlin, M. Jeffers-Terry, W. H. O'Brien, C. J. Stille, L. M. Young, and R. C. Antonelli
Targeted Child Psychiatric Services: A New Model of Pediatric Primary Clinician--Child Psychiatry Collaborative Care
Clinical Pediatrics, June 1, 2006; 45(5): 423 - 434.
[Abstract] [PDF]

Home page
 J Atten DisordHome page
L. Diller and S. Goldstein
Science, ethics, and the psychosocial treatment of ADHD.
J Atten Disord, May 1, 2006; 9(4): 571 - 574.
[PDF]

Home page
 AAP NewsHome page
R. L. Gorman
FDA panel recommends black box warning on ADHD stimulant medications
AAP News, April 1, 2006; 27(4): 16 - 16.
[Full Text]

Home page
 J Am Board Fam MedHome page
V. S. Bhatara, H. B. Vogt, S. Patrick, L. Doniparthi, and R. Ellis
Acceptability of a Web-based Attention-deficit/Hyperactivity Disorder Scale (T-SKAMP) by Teachers: A Pilot Study
J Am Board Fam Med, March 1, 2006; 19(2): 195 - 200.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
Committee on Child Health Financing
Scope of Health Care Benefits for Children From Birth Through Age 21
Pediatrics, March 1, 2006; 117(3): 979 - 982.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
J. E. Kemner and M. J. Lage
Effect of methylphenidate formulation on treatment patterns and use of emergency room services
Am. J. Health Syst. Pharm., February 15, 2006; 63(4): 317 - 322.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
T. E. Wilens, K. McBurnett, O. Bukstein, J. McGough, L. Greenhill, M. Lerner, M. A. Stein, C. K. Conners, J. Duby, J. Newcorn, et al.
Multisite Controlled Study of OROS Methylphenidate in the Treatment of Adolescents With Attention-Deficit/Hyperactivity Disorder
Arch Pediatr Adolesc Med, January 1, 2006; 160(1): 82 - 90.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
L. Furman
What Is Attention-Deficit Hyperactivity Disorder (ADHD)?
J Child Neurol, December 1, 2005; 20(12): 994 - 1002.
[Abstract] [PDF]

Home page
 PediatricsHome page
J. P. Guevara, C. Feudtner, D. Romer, T. Power, R. Eiraldi, S. Nihtianova, A. Rosales, J. Ohene-Frempong, and D. F. Schwarz
Fragmented Care for Inner-City Minority Children With Attention-Deficit/Hyperactivity Disorder
Pediatrics, October 1, 2005; 116(4): e512 - e517.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
M. E. Ruff
Attention Deficit Disorder and Stimulant Use: An Epidemic of Modernity
Clinical Pediatrics, September 1, 2005; 44(7): 557 - 563.
[PDF]

Home page
 J Atten DisordHome page
S. B. Wigal, J. J. McGough, J. T. McCracken, J. Biederman, T. J. Spencer, K. L. Posner, T. L. Wigal, S. H. Kollins, T. M. Clark, D. A. Mays, et al.
A Laboratory School Comparison of Mixed Amphetamine Salts Extended Release (Adderall XR(R)) and Atomoxetine (Strattera(R)) in School-Aged Children With Attention Deficit/Hyperactivity Disorder
J Atten Disord, August 1, 2005; 9(1): 275 - 289.
[Abstract] [PDF]

Home page
 J Atten DisordHome page
M. L. Wolraich, L. Bickman, E. W. Lambert, T. Simmons, and M. A. Doffing
Intervening to Improve Communication Between Parents, Teachers, and Primary Care Providers of Children With ADHD or at High Risk for ADHD
J Atten Disord, August 1, 2005; 9(1): 354 - 368.
[Abstract] [PDF]

Home page
 Psychiatr. Bull.Home page
D. Coghill
Attention-deficit hyperactivity disorder: should we believe the mass media or peer-reviewed literature?
Psychiatr. Bull., August 1, 2005; 29(8): 288 - 291.
[Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
J. A. Dopheide
ASHP Therapeutic Position Statement on the Appropriate Use of Medications in the Treatment of Attention-Deficit/Hyperactivity Disorder in Pediatric Patients
Am. J. Health Syst. Pharm., July 15, 2005; 62(14): 1502 - 1509.
[Full Text] [PDF]

Home page
 PediatricsHome page
T. J. Spencer, J. H. Newcorn, C. J. Kratochvil, D. Ruff, D. Michelson, and J. Biederman
Effects of Atomoxetine on Growth After 2-Year Treatment Among Pediatric Patients With Attention-Deficit/Hyperactivity Disorder
Pediatrics, July 1, 2005; 116(1): e74 - e80.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. L. Wolraich, C. J. Wibbelsman, T. E. Brown, S. W. Evans, E. M. Gotlieb, J. R. Knight, E. C. Ross, H. H. Shubiner, E. H. Wender, and T. Wilens
Attention-Deficit/Hyperactivity Disorder Among Adolescents: A Review of the Diagnosis, Treatment, and Clinical Implications
Pediatrics, June 1, 2005; 115(6): 1734 - 1746.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. T. Brown, R. W. Amler, W. S. Freeman, J. M. Perrin, M. T. Stein, H. M. Feldman, K. Pierce, M. L. Wolraich, and and the Committee on Quality Improvement, Subcommi
Treatment of Attention-Deficit/Hyperactivity Disorder: Overview of the Evidence
Pediatrics, June 1, 2005; 115(6): e749 - e757.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
H. A. Huskamp, P. A. Deverka, A. M. Epstein, R. S. Epstein, K. A. McGuigan, A. C. Muriel, and R. G. Frank
Impact of 3-Tier Formularies on Drug Treatment of Attention-Deficit/Hyperactivity Disorder in Children
Arch Gen Psychiatry, April 1, 2005; 62(4): 435 - 441.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. D. Rappley
Attention Deficit-Hyperactivity Disorder
N. Engl. J. Med., January 13, 2005; 352(2): 165 - 173.
[Full Text] [PDF]

Home page
 Journal of Emotional and Behavioral DisordersHome page
E. K. Coles, W. E. Pelham, E. M. Gnagy, L. Burrows-Maclean, G. A. Fabiano, A. Chacko, B. T. Wymbs, K. E. Tresco, K. S. Walker, and J. A. Robb
A Controlled Evaluation of Behavioral Treatment With Children With ADHD Attending a Summer Treatment Program
Journal of Emotional and Behavioral Disorders, January 1, 2005; 13(2): 99 - 112.
[Abstract] [PDF]

Home page
 PediatricsHome page
J. M. Foy and M. F. Earls
A Process for Developing Community Consensus Regarding the Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder
Pediatrics, January 1, 2005; 115(1): e97 - e104.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. K. Mulhern, R. B. Khan, S. Kaplan, S. Helton, R. Christensen, M. Bonner, R. Brown, X. Xiong, S. Wu, S. Gururangan, et al.
Short-Term Efficacy of Methylphenidate: A Randomized, Double-Blind, Placebo-Controlled Trial Among Survivors of Childhood Cancer
J. Clin. Oncol., December 1, 2004; 22(23): 4795 - 4803.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
D. Coghill
Use of stimulants for attention deficit hyperactivity disorder: FOR
BMJ, October 16, 2004; 329(7471): 907 - 908.
[Full Text] [PDF]

Home page
 BMJHome page
H. Marcovitch
Use of stimulants for attention deficit hyperactivity disorder: AGAINST
BMJ, October 16, 2004; 329(7471): 908 - 909.
[Full Text] [PDF]

Home page
 J Atten DisordHome page
C. M. Szobot, C. Ketzer, M. A. Parente, J. Biederman, and L. A. Rohde
The acute effect of methylphenidate in Brazilian male children and adolescents with ADHD: A randomized clinical trial
J Atten Disord, October 1, 2004; 8(2): 37 - 43.
[Abstract] [PDF]

Home page
 PediatricsHome page
I. W. Borowsky, S. Mozayeny, K. Stuenkel, and M. Ireland
Effects of a Primary Care-Based Intervention on Violent Behavior and Injury in Children
Pediatrics, October 1, 2004; 114(4): e392 - e399.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
L. Furman and B. W. Berman
Rethinking the AAP Attention Deficit/Hyperactivity Disorder Guidelines
Clinical Pediatrics, September 1, 2004; 43(7): 601 - 603.
[PDF]

Home page
 PediatricsHome page
J. L. Rushton, K. E. Fant, and S. J. Clark
Use of Practice Guidelines in the Primary Care of Children With Attention-Deficit/Hyperactivity Disorder
Pediatrics, July 1, 2004; 114(1): e23 - e28.
[Abstract] [Full Text] [PDF]

Home page
 J Atten DisordHome page
V. Bhatara, M. Feil, K. Hoagwood, B. Vitiello, and B. Zima
National trends in concomitant psychotropic medication with stimulants in pediatric visits: Practice versus knowledge
J Atten Disord, May 1, 2004; 7(4): 217 - 226.
[Abstract] [PDF]

Home page
 PediatricsHome page
J. M. Swanson, S. B. Wigal, T. Wigal, E. Sonuga-Barke, L. L. Greenhill, J. Biederman, S. Kollins, A. S. Nguyen, H. H. DeCory, S. J. Hirshe Dirksen, et al.
A Comparison of Once-Daily Extended-Release Methylphenidate Formulations in Children With Attention-Deficit/Hyperactivity Disorder in the Laboratory School (The Comacs Study)
Pediatrics, March 1, 2004; 113(3): e206 - 216.
[Abstract] [Full Text] [PDF]

Home page
 J Atten DisordHome page
T. D. Topolski, T. C. Edwards, D. L. Patrick, P. Varley, M. E. Way, and D. P. Buesching
Quality of life of adolescent males with Attention-Deficit Hyperactivity Disorder
J Atten Disord, February 1, 2004; 7(3): 163 - 173.
[Abstract] [PDF]

Home page
 PediatricsHome page
A. S. Yusin, J. M. Perrin, M. Wolraich, and M. Stein
2001 American Academy of Pediatrics Practice Parameter on Attention-Deficit/Hyperactivity Disorder
Pediatrics, February 1, 2004; 113(2): 428 - 429.
[Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
L. S Eiland and A. L Guest
Atomoxetine Treatment of Attention-Deficit/Hyperactivity Disorder
Ann. Pharmacother., January 1, 2004; 38(1): 86 - 90.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
D. Dougherty and L. A. Simpson
Measuring the Quality of Children's Health Care: A Prerequisite to Action
Pediatrics, January 1, 2004; 113(1/S1): 185 - 198.
[Abstract] [Full Text] [PDF]

Home page
 J Pediatr PsycholHome page
M. L. Wolraich, W. Lambert, M. A. Doffing, L. Bickman, T. Simmons, and K. Worley
Psychometric Properties of the Vanderbilt ADHD Diagnostic Parent Rating Scale in a Referred Population
J. Pediatr. Psychol., December 1, 2003; 28(8): 559 - 568.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
C. A. Lesesne, S. N. Visser, and C. P. White
Attention-Deficit/Hyperactivity Disorder in School-Aged Children: Association With Maternal Mental Health and Use of Health Care Resources
Pediatrics, May 1, 2003; 111(5): 1232 - 1237.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
J. M. REY and M. G. SAWYER
Are psychostimulant drugs being used appropriately to treat child and adolescent disorders?
The British Journal of Psychiatry, April 1, 2003; 182(4): 284 - 286.
[Full Text] [PDF]

Home page
 J Pediatr PsycholHome page
R. T. Brown
Introduction to the Special Issue: Training in Pediatric Psychology
J. Pediatr. Psychol., March 1, 2003; 28(2): 81 - 83.
[Full Text] [PDF]

Home page
 Pediatr. Rev.Home page
M. T. Stein and J. M. Perrin
Diagnosis and Treatment of ADHD in School-age Children in Primary Care Settings: A Synopsis of the AAP Practice Guidelines
Pediatr. Rev., March 1, 2003; 24(3): 92 - 98.
[Full Text] [PDF]

Home page
 PediatricsHome page
E. R. Cox, B. R. Motheral, R. R. Henderson, and D. Mager
Geographic Variation in the Prevalence of Stimulant Medication Use Among Children 5 to 14 Years Old: Results From a Commercially Insured US Sample
Pediatrics, February 1, 2003; 111(2): 237 - 243.
[Abstract] [Full Text] [PDF]

Home page
 The Journal of School NursingHome page
J. Selekman
Attention-Deficit/Hyperactivity Disorder
The Journal of School Nursing, October 1, 2002; 18(5): 270 - 276.
[Abstract] [Full Text] [PDF]

Home page
 AAP NewsHome page
D. Johnson
Getting your arms around ADHD: New tools help pediatricians implement Academy's recent diagnostic guidelines
AAP News, August 1, 2002; 21(2): 64 - 64.
[Full Text] [PDF]

Home page
 Pediatr. Rev.Home page
E. H. Wender
Managing Stimulant Medication for Attention-Deficit/Hyperactivity Disorder: An Update
Pediatr. Rev., July 1, 2002; 23(7): 234 - 236.
[Full Text]

Home page
 JWatch PediatricsHome page
How to Diagnose and Treat ADHD: New AAP Guidelines
Journal Watch Pediatrics and Adolescent Medicine, April 16, 2002; 2002(416): 10 - 10.
[Full Text]